期刊文献+

前列腺癌新型靶向纳米超声造影剂的合成及初步评价 被引量:1

Preparation of a Novel Nano Ultrasound Contrast Agent Targeting at Prostate Cancer
下载PDF
导出
摘要 目的:研究制备一种前列腺癌新型靶向性纳米超声造影剂。方法:采用PEG及抗前列腺癌特异性膜抗原(PSMA)适体A10-3.2修饰多壁碳纳米管(MWCNTs)合成新型靶向纳米超声造影剂,对其进行合成验证、体外特征评价、生物相容性研究及体外显影评价。结果:Zeta电位、透射电镜扫描图(TEM)、红外分析图(FT-IR)均表明此靶向纳米造影剂合成成功。体外细胞学研究表明,该造影剂细胞毒性小、生物相容性好。体外显影结果表明,该造影剂具有良好的显影效果。结论:该新型造影剂制备成功,具备靶向显影的潜能。 Objective:To prepare a prostate cancer targeted nano-ultrasound contrast agent.Methohs:Multi-walled carbon nanotubes(MWCNTs) were modified by PEG and anti-PSMA aptamers,and the resulted products were researched on their characteristics,biological compatibility as well as development in vitro.Results:Zeta potential,transmission electron microscopy(TEM) and infrared analysis(FT-IR) results showed that this targeted nano contrast agent had been successfully synthesized.In vitro cytology showed that the contrast agent had good biocompatibility.The contrast agent had good development effects outside the body.Conclusion:The novel contrast agent has been prepared sucessfully with the potential for prostate cancer targeting development.
作者 顾芬芬 胡楚玲 台宗光 高申 陈中建 GU Fenfen1,2,HU Chuling2,TAI Zongguang2,GAO Shen2,CHEN Zhongjian3(1Department of Pharmacy, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, No. 1665 Kongjiang Road, Yangpu District, Shanghai 200092, China;2Department of Pharmacy, Changhai Hospital, Second Military Medical University, No.168 Changhai Road, Yangpu District, Shanghai 200092, China;3Department of Pharmacy, Shanghai Dermatology Hosptial, No.200, Wuyi Road, Changning District, Shanghai 200050, Chin)
出处 《药学与临床研究》 2018年第4期257-260,共4页 Pharmaceutical and Clinical Research
关键词 多壁碳纳米管 适体 纳米靶向造影剂 前列腺癌 Multi-walled carbon nanotubes Aptamer Targeted nano contrast agent Prostate cancer
  • 相关文献

参考文献2

二级参考文献95

  • 1施斌,方超,游美羡,裴元英.聚乙二醇修饰对羟喜树碱隐形纳米囊泡的肿瘤靶向和抑瘤作用的影响[J].中国临床药学杂志,2006,15(1):46-49. 被引量:15
  • 2Wang HJ,Zhao PQ,Liang XF,et al.Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug delivery[J].Biomaterials,2010,31(14):4129-38.
  • 3Song SX,Liu D,Peng JL,et al.Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo[J].FASEB J,2009,23(5):1396-404.
  • 4Jung SH,Jung HS,Seong H,et al.Polyethylene glycolcomplexed cationic liposome for enhanced cellular uptake and anticancer activity[J].Int J Pharm,2009,382 (1-2):254-61.
  • 5Hong MH,Zhu SJ,Jiang YY,et al.Novel anti-tumor strategy:PEG -hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles[J].J Control Release,2010,141 (1):22-9.
  • 6Orditura M,Quaglia F,Morgillo F,et al.Pegylated liposomal doxorubicin pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity[J].Oncol Rep,2004,12 (3):549-56.
  • 7Dadashzadeh S,Vall AM,Rezaie M.The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats[J].Int J Pharm,2008,353 (2):251-9.
  • 8Yang T,Choi MK,Cui FD,et al.Preparation and evaluation of paclitaxel -loaded PEGylated immunolip osome[J].J Control Release,2007,120(3):169-77.
  • 9Ryo S,Tomoko T,Yasubiro K,et al.Effective antitumor activity of oxaliplatin encapsulated in transferring -PEG-liposome[J].Int J Pharm,2008,346(2):143-50.
  • 10Phan G,Herbet A,Cholet S,et al.Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation[J].J Control Release,2005,110(1):177-88.

共引文献5

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部